
Beta Drugs Share Price
₹1,690.00 -6.15 (-0.36%)
12 Mar, 2025 07:27
Start SIP in
BETA
Performance
- Low
- ₹1,681
- High
- ₹1,705
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹1,695
- Previous Close₹1,696
- Volume1,300
Investment Returns
- Over 1 Month -2.95%
- Over 3 Month -24.39%
- Over 6 Month -3.97%
- Over 1 Year + 41.97%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.6
- PEG Ratio
- -
- Market Cap Cr
- 1,625
- P/B Ratio
- 9
- Average True Range
- 93.28
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- -53.56
- RSI
- 45.48
- MFI
- 29.84
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,690.00
-6.15
(-0.36%)

-
- Bearish Moving Average 14
-
- Bullish Moving Average 2
- 20 Day
- ₹1,726.88
- 50 Day
- ₹1,810.61
- 100 Day
- ₹1,827.90
- 200 Day
- ₹1,717.04
Resistance and Support
1692
- R3 1,727.00
- R2 1,716.00
- R1 1,703.00
- S1 1,679.00
- S2 1,668.00
- S3 1,655.00
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-05 | Issue of Bonus & Others | To consider other business matters. |
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,690 As on 12 March, 2025 | 07:13
The Market Cap of Beta Drugs is ₹1624.7 Cr As on 12 March, 2025 | 07:13
The P/E ratio of Beta Drugs is 44.6 As on 12 March, 2025 | 07:13
The PB ratio of Beta Drugs is 9 As on 12 March, 2025 | 07:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.